Evidence map›Paper›PMID 40365988›Full record

SynthesisImmunity, inflammation and disease2025

Determinants of Malaria Vaccine Acceptance: A Systematic Review and Meta-Analysis of Awareness, Acceptance, Hesitancy, and Willingness to Pay.

Ganesh Bushi, Mahalaqua Nazli Khatib, Renuka Jyothi S, Irwanjot Kaur, Abhishek Sharma, Suhaib Iqbal, M Ravi Kumar, Ashish Singh Chauhan, Teena Vishwakarma, Praveen Malik and 15 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Immunity, inflammation and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Ganesh BushiSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
Mahalaqua Nazli KhatibDivision of Evidence Synthessis, Global Consortium of Public Health and Research, Datta Meghe Institute of Higher Education, Wardha, Maharashtra, India.
Renuka Jyothi SDepartment of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
Irwanjot KaurDepartment of Allied Healthcare and Sciences, Vivekananda Global University, Jaipur, Rajasthan, India.
Abhishek SharmaDepartment of Medicine, NIMS University, Jaipur, Rajasthan, India.
Suhaib IqbalChandigarh Pharmacy College, Chandigarh Group of College, Jhanjeri, Mohali, Punjab, India.
M Ravi KumarDepartment of Chemistry, Raghu Engineering College, Visakhapatnam, Andhra Pradesh, India.
Ashish Singh ChauhanDivision of Research and Innovation, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, Uttarakhand, India.
Teena VishwakarmaIES Institute of Pharmacy, IES University, Bhopal, Madhya Pradesh, India.
Praveen MalikNew Delhi Institute of Management, Delhi, India.
Quazi Syed ZahiruddinSouth Asia Infant Feeding Research Network, Division of Evidence Synthesis, Global Consortium of Public Health and Research, Datta Meghe Institute of Higher Education, Wardha, Maharashtra, India.
Mahendra Pratap SinghCenter for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India.
Muhammed ShabilUniversity Center for Research and Development, Chandigarh University, Mohali, Punjab, India.
Rachana MehtaClinical Microbiology, RDC, Manav Rachna International Institute of Research and Studies, Faridabad, Haryana, India.ORCID 0000-0003-4771-4089
Sanjit SahDepartment of Pediatrics, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed-to-be-University), Pimpri, Pune, India.ORCID 0009-0008-5017-083X
Hawra AlbayatInfectious Disease Department, King Saud Medical City, Riyadh, Saudi Arabia.
Tarek SulaimanInfectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh, Saudi Arabia.
Ali Al BshabsheAdult critical care Department of medicine, Division of adult critical care, College of medicine, King Khalid University, Abha, Saudi Arabia.
Nawal A Al KaabiCollege of Medicine and Health Science, Khalifa University, Abu Dhabi, United Arab Emirates.
Hayam A AlrasheedDepartment of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Mubarak AlfaresiDepartment of Microbiology, National Reference Laboratory, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Amal A SabourDepartment of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Eman AlamriFood Science and Nutrition, Faculty of Science, University of Tabuk, Tabuk, Saudi Arabia.
Maha F Al-SubaieResearch Center, Dr. Sulaiman Alhabib Medical Group, Riyadh, Saudi Arabia.
Ali A RabaanCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

Funding

The authors received no specific funding for this work.
6 · The paper itself

Abstract

backgroundMalaria is a life-threatening disease caused by Plasmodium parasites, transmitted through the bites of infected female Anopheles mosquitoes. It remains a major global health issue, with 263 million cases and 597,000 deaths in 2023, primarily affecting young children and pregnant women. This review evaluates awareness, acceptance, hesitancy, and willingness to pay (WTP) for the RTS,S/AS01 malaria vaccine, along with the key factors influencing these outcomes.

methodsA comprehensive literature search was conducted in Web of Science, PubMed, and Embase, covering publications up to 18 June 2024. Observational studies assessing awareness, acceptance, hesitancy, and WTP for the malaria vaccine in endemic regions were included. Two independent reviewers screened the studies. Data extraction was performed using Nested Knowledge software and analyzed with R v.4.4. Pooled prevalences were estimated using random-effects models, and heterogeneity was assessed with the I² statistic.

resultsEighteen studies with 21,975 participants provided insights into malaria vaccine dynamics: 32% awareness (95% CI, 18%-50%), 83% acceptance (95% CI, 75%-89%), 14% hesitancy (95% CI, 7%-26%), and 58% WTP (95% CI, 34%-79%). Key determinants of acceptance included age, where younger adults (18-24 years) showed lower acceptance (OR = 0.64, 95% CI, 0.35-0.93). Employment, particularly farmers, had higher acceptance rates (OR = 3.20, 95% CI, 1.00-7.40). Lower socioeconomic status and larger family sizes were associated with decreased acceptance (OR = 0.18, 95% CI, 0.02-0.38).

conclusionThis review revealed an 83% acceptance rate for the malaria vaccine, with variability in awareness (32%), hesitancy (14%), and willingness to pay (58%). Age, employment, and socioeconomic status were significant determinants of acceptance. However, due to potential publication bias and high heterogeneity, these findings should be cautiously interpreted. The results highlight the necessity for targeted interventions to enhance vaccine acceptance. Further research is required to elucidate factors that influence vaccine acceptance.

Indexed as

Health Knowledge, Attitudes, PracticeMalariaMalaria VaccinesPatient Acceptance of Health CareVaccination HesitancyFemaleHumansMalaria Vaccinesacceptanceawarenesshesitancymalaria vaccinesystematic reviewwillingness to pay

Identifiers

PMID40365988
PMCPMC12076350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.